A Chinese woman experiencing neurological symptoms who had a stroke at age 30 was ultimately diagnosed with the blood disorder hereditary thrombotic…
News
Pharma companies Galapagos and Gilead are in talks for a potential collaboration to develop gamgertamig, an experimental therapy for immune thrombocytopenia (ITP)…
A new case study describes a family with platelet-type von Willebrand disease (PT-VWD), a rare bleeding condition often mistaken for von Willebrand disease (VWD).
Adding Cablivi (caplacizumab) to therapeutic plasma exchange (TPE) and corticosteroids may lead to a faster treatment response and durable disease remission in people with…
Adjusting the dose of oral eltrombopag — the active ingredient in Alvaiz and Promacta — based on how much of the drug is present in…
Celebrities and advocacy groups are teaming up to raise awareness of bleeding disorders with a three-hour livestream celebrating the community. The March 28 event, “Bleeding.org…
Congenital thrombotic thrombocytopenic purpura (TTP) typically develops in infancy or early childhood, but clinicians have now reported a rare case involving a young woman…
A group of U.S. treatment centers worked together to standardize care for children with immune thrombocytopenia (ITP), leading to more patients receiving treatment that…
A woman in her 40s with persistent heavy menstrual bleeding was safely treated with surgery after doctors diagnosed her with von Willebrand disease (VWD),…
People with thrombotic thrombocytopenic purpura (TTP) who are hospitalized on weekends face no increased risk of worse outcomes than those admitted on weekdays, according…
